Moderna | MRNA - Market Capitalization

Stock Price
42.88
Daily Change
0.68 1.61%
Monthly
33.29%
Yearly
22.58%
Q1 Forecast
42.71

Moderna reported $16.34B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
Arrowhead Research USD 4.77B 2.59B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Celltrion KRW 40.04T 3.19T Sep/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.51T 297.32B Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 86.59B 22.54B Feb/2026
Incyte USD 16.56B 3.38B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Laboratorios Farma EUR 3.68B 430.05M Jan/2026
Malin Corporation EUR 150.45M 12.13M Jan/2026
Moderna USD 10.09B 581M Sep/2025
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Pharma Mar EUR 1.63B 241.7M Sep/2025
Qiagen NV USD 9.69B 719.54M Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Sartorius EUR 8.36B 8.04B Feb/2026
Sino Biopharmaceutical CNY 90.06B 33.55B Jun/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025